Research Articles | Page 95 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
How I Treat Paroxysmal nocturnal hemoglobinuria Jan 2021 Blood paroxysmal nocturnal hemoglobinuria (PNH)
Eltrombopag for refractory severe aplastic anemia: dosing, duration, long term outcomes and clonal evolution Apr 2019 Blood aplastic anemia
Newly revised 2023 MDS response criteria Apr 2023 Blood myelodysplastic syndromes (MDS)
"Moderate" dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution Sep 2014 Blood aplastic anemia
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes Apr 2023 Blood myelodysplastic syndromes (MDS)
Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976;48(1):63-70 Nov 2016 Blood aplastic anemia
A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes Oct 2016 Biomed Pharmacother myelodysplastic syndromes (MDS)
Diagnosis of paroxysmal nocturnal hemoglobinuria in peripheral blood and bone marrow with six-color flow cytometry. Feb 2012 Biomark Med paroxysmal nocturnal hemoglobinuria (PNH)
Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease Jan 2018 Biology of Blood and Marrow Transportation graft versus host disease (GVHD)
The case for upfront HLA-matched unrelated donor HCT as a curative option for adult acquired severe aplastic anemia: Upfront MUD HCT for adult severe aplastic anemia May 2019 Biology of Blood and Marrow Transplantation: Journal of the American Society of Blood and Marrow Transplantation aplastic anemia
Share with addtoany.com.